Basically what happened was that Appeals Court reversed a district court
decision on Friday and allowed Teva to seek declaratory judgment against
Novartis on several patents related to Famciclovir. This was kind of
expected after Supreme Court's MedImmune decision. Now as it turns into
reality, we probably will see broad impact to the generic industry.
